Sources sought
Electroporation System
36C24725Q0598
Department of Veterans Affairs, 247-Network Contract Office 7. Research and Development in Biotechnology (except Nanobiotechnology).
Awarded
$49,680.00 obligated so far on USAspending
Get the next one like this from Department of Veterans Affairs by email, the day it is posted.Find my opportunities
This one was awarded in 2025
18 like it are open now in research and development in biotechnology (except nanobiotechnology)
- Development/Production - Kidney GEC-Specific AAV Vector
Department of Veterans Affairs, Rpo East
Sources soughtNAICS 541714Columbia, MO36C24E27Q0009Closes in 3 daysNov 4 - AMPLICON SEQUENCING SERVICES
US Geological Survey, Ofc of Acquisition Grants-Denver
SolicitationNAICS 541714Location not published140G0226Q0047Closes in 4 daysNov 5 - High-throughput Unmasking of Biological Interactomes with Binding Landscape Emulators (HUBBLE)
Defense Advanced Research Projects Agency, Def Advanced Research Projects Agcy
SolicitationNAICS 541714Anywhere in the USDARPA-PA-27-01Closes in 5 daysNov 5
All 18 open in research and development in biotechnology (except nanobiotechnology)
Description
As published on SAM.gov.
This is a sources sought announcement only. All responses will be used for market analysis in determining the availability of potential qualified businesses that may be used to determine appropriate acquisition strategy. No solicitation is being issued at this time but may be issued later.
The Columbia Healthcare VA System (WJB Dorn VA Medical Center) located at 6439 Garners Ferry Road, Columbia, SC 29209 is seeking Service-Disabled Veteran Owned Small Businesses (SDVOSB), Veteran Owned Small Businesses (VOSB) and vendors falling into other socioeconomic Small Business (SB) categories to provide an Electroporation System which meet or exceed all stated salient characteristics identified below.
The system should have both non-GMP and clinical-grade options, where the non-GMP version is designed to be compatible with a clinical-grade counterpart system. This implies a modular or flexible system architecture where different "modes" or "grades" of operation can be selected depending on the application. The system must offer capabilities for the high-performance delivery of virtually any molecule into various cell types, including primary cells, stem cells, and cell lines.
The system must possess ability to rapidly transfect a wide range of cell quantities, from as few as 75 thousand up to 700 million cells, providing the flexibility required for diverse experimental and production demands. The system must work seamlessly with all MaxCyte static Processing Assemblies. The system must possess the ability to facilitate a smooth transition from laboratory to clinical Good Manufacturing Practice (GMP) environments.
The system must be able to support rapid translation from concept to clinic. The system must include an Integrated Touch-Screen interface that allows for easy operation and quick access to instrument functionalities. The system must include an Enhanced Software User Interface that provides intuitive use and additional operational capabilities. The system must include LED Status Indicators that offer clear visual cues regarding instrument and run status through six distinctly colored modes.
The system must possess a Space-Efficient Design. The system must possess Shared Local Drive Access enables automatic report generation and saving, streamlining data management. The system must allow for Electronic Signatures help minimize transcription errors, enhancing data integrity. The system must include User Authentication which reduces the number of passwords needed, improving security and user management.
The system must include an API (Application Programming Interface) compatibility allows for integration into existing manufacturing automation systems, facilitating streamlined operations and data flow. Interested offerors are encouraged to respond to this notice via e-mail and provide their companies name and associated Unique Entity Identifier (UEI) number.
This notice will be posted for a period of 3 business days, closing on Thursday, May 1, 2025, at 10am EST. Questions regarding this notice should be forwarded to Joseph Locke via e-mail at joseph.locke@va.gov
The contract, on USAspending
Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.
- Recipient
- Maxcyte, Inc.
- UEI
- KM8DZV21HFM8
- CAGE
- 47CG7
- Vendor location
- Rockville, MD
- Contract
- 36C24725P0739, purchase order
- Obligated
- $49,680.00
- Actions
- 1 between May 28, 2025 and May 28, 2025
- Competition
- Not Competed Under SAP, 1 offer received
- Set-aside reported
- No Set Aside Used.
- Described as
- Maxcyte Expert Atx Electroporation System
- Match
- solicitation number 36C24725Q0598 equals the FPDS solicitation identifier; same awarding office 36C247 (high confidence)
- Record
- USAspending award page
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
April 29, 2025
Sources sought
Due May 1, 2025 at 10:00 AM EDT. SAM.gov, notice 0915e2f738904acaae842a63cd0ea69f
Points of contact
- Joseph Locke, Contracting OfficerJoseph.locke@va.gov803-776-4000 x7814